Correlation Between Agios Pharm and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and X4 Pharmaceuticals, you can compare the effects of market volatilities on Agios Pharm and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and X4 Pharmaceuticals.
Diversification Opportunities for Agios Pharm and X4 Pharmaceuticals
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Agios and XFOR is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Agios Pharm i.e., Agios Pharm and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Agios Pharm and X4 Pharmaceuticals
Given the investment horizon of 90 days Agios Pharm is expected to generate 2.93 times less return on investment than X4 Pharmaceuticals. But when comparing it to its historical volatility, Agios Pharm is 5.16 times less risky than X4 Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 404.00 in X4 Pharmaceuticals on June 4, 2025 and sell it today you would lose (28.00) from holding X4 Pharmaceuticals or give up 6.93% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agios Pharm vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Agios Pharm |
| X4 Pharmaceuticals |
Agios Pharm and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agios Pharm and X4 Pharmaceuticals
The main advantage of trading using opposite Agios Pharm and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Agios Pharm vs. Ultragenyx | Agios Pharm vs. Crinetics Pharmaceuticals | Agios Pharm vs. Arvinas | Agios Pharm vs. Revolution Medicines |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |